Tag "Food and Drug Administration"

26 April 2017, 19:34
The US FDA calls it "cruel deception": companies promising desperate consumers that their products can cure cancer.
On Tuesday, the agency responsible for policing the American food and drug market issued warning letters to 14 companies that it says are "illegally selling more than 65 products that fraudulently claim to prevent, diagnose, treat or cure cancer."

30 March 2017, 18:01
Dr. Scott Gottlieb, President Donald Trump's nominee to head the FDA, is a widely respected physician and prominent conservative health care thinker. He also has some serious financial ties to the industry he's tasked with overseeing if ultimately confirmed by the Senate.
Gottlieb has received millions of dollars in compensation from some 20-odd biopharma and health firms, according to financial disclosure documents reported by the Wall Street Journal.

28 March 2017, 18:37
President Donald Trump is planning to take the ax to Food and Drug Administration regulations. “[We’re] going to be streamlining the process so that, from your standpoint, when you have a drug, you can actually get it approved instead of waiting for many, many years,” he told a collection of Big Pharma CEOs, including the chief executives of Merck, Novartis and Johnson & Johnson, during a White House meeting earlier this year.

24 March 2017, 17:26
Global advancements have changed the way we provide and receive health care. Early diagnosis, quick surgical procedures, reduced postoperative hospital stays, painless treatments and various innovative solutions have become norms of providing health care. These developments and solutions have been crafted by many players such as health experts, technology experts, research houses and consumer communities. The following are trends shaping medical devices today, and will continue to do so in the years to come.
Home is the health care hub
The very atmosphere of home cures many. This common mind-set of patients has triggered the need for easy-to-use home health care devices. The wireless home-care device segment alone is expected to touch $6 billion by 2017 in the U.S. This market is growing in the form of various new applications of smart medical devices such as remote patient monitoring, miniaturized ultra-low power devices, zero-defect reliability, and all-in-one devices are some of the most popular advanced device traits and technologies addressing the home health care market.

06 March 2017, 14:11
In his first address to a joint session of Congress, President Donald Trump made a dramatic appeal for lowering the hurdles new medicines face in gaining approval from the Food and Drug Administration. But Trump’s promises–that reduced regulatory standards would result in more cures reaching the market and lower drug prices–may be hard to keep.

10 February 2017, 18:17
President Donald Trump wants to remake the Food and Drug Administration. And he happens to have a “fantastic person” in mind to do it, he said Tuesday — someone who will turn the agency into an industry-friendly shop that cranks out new cures on the double.

20 January 2017, 18:09
Critics of the Food and Drug Administration, including at least one person under consideration to serve as its commissioner, accuse the agency of unnecessarily dragging out the drug approval process at a cost to both manufacturers and desperately ill patients.

29 December 2016, 19:20
With the number of class action lawsuits brought against food and beverage manufacturers over allegedly poor labeling and marketing on the rise, companies and their attorneys are looking for more guidance from the U.S. Food and Drug Administration.

Consider the life of a chef on the road. Even when they’re not doing “research” for an upcoming project—trips that are essentially designed for overeating and drinking—they’re still likely seeking the best of what got them into the industry in the first place: damn good food.

The proliferation of low-cost airlines flying out of the U.S. means that it’s now possible to hop to Europe for as low as half the price charged by major carriers, the New York Times writes. But there’s always a trade-off — and it pays to comparison-shop, according to the publication.

Featured Contributors

Chasing snake oil and fad gurus is harmless until your journey of personal discovery becomes a platform for prescribing therapies to complete strangers. Any reasonably diligent venture capital partner should be weighing the risks.

Shkreli — who famously insulted members of Congress earlier this year but refused to testify officially over his own decision to increase the price of a life-saving pill — is now hopping at the chance to defend generic drug manufacturer Mylan.
He may even have opened the door to testify before the House Committee on Oversight and Government Reform, where he previously cited his Fifth Amendment's right to avoid incriminating himself.
"Any chance i can come through this time and actually testify?" he tweeted Thursday in a post directed at the committee's Democrats.
All of this now paves an unlikely new friendship between Shkreli and Mylan CEO Heather Bresch.
Heather Bresch created about $15 billion in value for Mylan in the seven years since she stepped up as president of the company. A big part of that value add came from her talent for repackaging off-the-shelf drugs into bona fide blockbusters.

Donald Trump is talking about Hillary Clinton’s health, as are two doctors who havenever evaluated Clinton. They have apparently diagnosed her with all kinds of ailments using the long disproven Fox-Drudge equation.
This attention on Clinton has renewed some interest in the letter Donald Trump released last year from his personal physician.

Even as doctors enter a medical field with more paying patients under the Affordable Care Act and unprecedented numbers of job opportunities, 25 percent of “newly trained physicians” would still choose another field if they could, according to a new analysis.